What Vidisic Gel Treats: Main Uses and Benefits

Vidisic Gel is a lubricant designed to act as an artificial tear for the symptomatic treatment of dry eye. It is relevant in conditions characterized by periods of heightened symptoms. These conditions commonly include keratoconjunctivitis sicca (KCS) and related states of ocular surface dryness.

The gel is relevant for easing symptoms related to physical discomfort, often used during phases when symptoms become more noticeable, such as feelings of dryness, burning, foreign body sensation, or soreness. Vidisic is used to manage these symptoms, acting as an artificial tear when the eyes are lacking moisture.

The primary benefit is that the formulation assists with improving day-to-day comfort during symptomatic periods. This provides supportive relief when symptoms of dryness or irritation interfere with routine activities. It is commonly used when short-term symptomatic assistance is needed in clinical settings that involve acute or unstable symptom patterns.

---

Quick Fact: Supports general well-being during symptomatic phases related to physical discomfort.

---

Regulatory References

1. Vidisic 0.2% w/w Eye Gel HPRA

Who Can and Cannot Use Vidisic Gel?

Eligibility for Vidisic Gel (Carbomer 0.2% w/w) is strictly defined by regulatory guidelines, focusing on populations that are prohibited from use and those requiring conditional use.

Official Contraindications

• Hypersensitivity: The gel is contraindicated in patients with a known allergy or hypersensitivity to the active substance (Carbomer) or to any of the other excipients.
• Ocular Status: Use is prohibited if the patient has undiagnosed conjunctivitis (an eye infection).

---

Age-Related and Special Population Rules

Population	Regulatory Status
Adults and the Elderly	Use is established and generally accepted.
Children and Adolescents	Efficacy and safety are established by clinical experience, but official documents note the absence of clinical trial data for this age group.
Pregnancy and Lactation	Safety has not been established. Use is conditional and requires a physician's determination that the potential benefits outweigh the risks.

This structure ensures adherence to regulatory constraints by defining clear exclusions and limiting use in vulnerable groups where safety data is incomplete.

Interactions with other medicines and products

Vidisic Gel, which contains the active ingredient Carbomer 980, functions as a highly viscous lacrimal fluid substitute applied topically to the eye. Due to its high molecular weight and primarily physical mode of action on the ocular surface, the medicine has no documented systemic metabolic or transporter-based drug-drug interactions in official regulatory sources. Systemic absorption of the active ingredient is considered negligible, meaning it is not expected to interact with oral or non-ocular medicines at a pharmacological level.

Administration-Timing Interaction Rules

The sole documented interaction pattern involves physical interference with other topical ophthalmic preparations, classified as an administration-timing interaction. The high viscosity of the gel can mechanically impede the absorption of subsequently applied solutions or suspensions.

Interacting Substances	Interaction Type	Regulatory Restriction
Other eye drops or ointments	Physical Interference	Requires a mandatory time separation

For co-administration, Vidisic Gel must always be the last ophthalmic preparation applied to the eye. A time interval of at least 15 minutes must be observed following the application of any other eye drops or eye ointments before Vidisic Gel is instilled. Official regulatory documents do not list any medicinal products formally classified as contraindicated combinations, nor do they specify interactions with food, alcohol, herbal products, or supplements.

The mechanism of Vidisic Gel (Carbomer 980) is entirely physicochemical and mechanical, acting to mimic the function of the natural tear film rather than through pharmacological signaling. This action involves three core mechanistic domains on the ocular surface.

Mucoadhesion and Ocular Surface Adherence

This mechanism describes how the Carbomer polymer physically interacts with the eye's natural mucin layer, which functions as its primary mechanical target. This crucial mucoadhesion ensures the polymer resists clearance, significantly prolonging its precorneal residence time to establish a sustained physical layer on the ocular surface.

Controlled Water Release and Hydration Dynamics

The polymer acts as a hydrophilic reservoir, sequestering a large volume of water. The continuous, slow release of this bound moisture is triggered by a physiochemical interaction with the salts and electrolytes present in the tear fluid, which progressively breaks down the gel structure. This cascade supports the regulation of local hydration dynamics.

Mechanical Friction Reduction

By forming a stable, high-viscosity lubricating film, the gel physically reduces the high coefficient of friction that occurs when the eyelid moves over the epithelium. This physical action targets the primary mechanical irritant, friction, and limits the impact of mechanical shear stress on the surface barrier.

How Vidisic Gel is Used: Official Administration Guidelines

Vidisic Gel is a specialized sterile ophthalmic gel containing Carbomer 0.2% w/w, intended solely for ocular administration. Its usage is standardized to ensure the viscous gel correctly supports the ocular surface. The official instructions focus on the prescribed dosage, frequency, and critical administration timing to maintain its film-forming properties.

---

Administration Scope

Entity	Official Administration Rules
Route of Administration	Topical ocular use; instilled into the conjunctival sac only.
Standard Dosing Schedule	One drop per dose.
Frequency Pattern	Typically applied 3 to 5 times per day, with an application scheduled before retiring for the night. Frequency may be increased as required by the patient's symptomatic needs.

---

Contextual Use and Procedural Constraints

The established protocol requires adherence to specific timing rules, particularly concerning the use of other ophthalmic products and contact lenses:

• Sequential Administration: Vidisic Gel must be the last eye preparation applied when used concurrently with other topical eye medications. A strict interval of 15 minutes must be maintained after instilling the previous product.
• Contact Lens Management: Contact lenses must be removed before the gel is administered. Lenses may be reinserted 15 minutes after application.
• Pediatric Use: The adult dosing regimen is applied to children and adolescents (up to 18 years).

These instructions define the standardized method for applying the medicine, ensuring its viscous nature is not diluted prematurely and supporting proper ocular contact.

Research evidence / Overview of studies for Vidisic Gel

---

Evidence for Use in Dry Eye Syndrome

Research has focused on the gel's role as a substitute for natural tears, primarily exploring how symptom patterns were observed in people with dry eye syndrome who were participating in studies. Studies conducted during periods of increased symptom activity include Randomized Controlled Trials (RCTs). These trials often compare the gel against an inactive substance (placebo) or against other common tear substitutes. Researchers examined outcomes related to patient-reported experiences of physical discomfort, such as dryness, burning, and the foreign body sensation.

Research examined both the patient's subjective experience and objective signs of dry eye. Objective signs examined by researchers included the Tear Film Break-Up Time (TBUT), a measure of tear film stability, and specific staining scores that monitor ocular surface health. Studies reported patterns where symptom scores were measured and tracked across the observed populations. Evidence contributes to understanding symptom patterns, particularly in episodes where symptoms became more noticeable.

Focus on Carbomer’s Physical Properties and Residence Time

Research has explored the specific physical characteristics of the main ingredient, Carbomer. These pharmacodynamic studies examined how the gel physically interacts with the eye surface. The mucoadhesive properties of the carbomer ingredient—its physical ability to adhere to the eye’s protective mucus layer—were studied. Research describes patterns related to a longer measured Precorneal Residence Time (PRT) for the gel formulation compared to less viscous drops. This evidence helps contextualize the physical properties observed in the research.

Main Evidence Gaps and Areas of Research Uncertainty

The research highlights what is known and what is still uncertain about this medicine. One key limitation is that evidence quality varies across studies, leading to findings that were mixed, particularly regarding changes in the objective signs of dry eye. The inconsistency in objective findings, such as those related to the Schirmer test score, indicates that certainty remains low in these specific areas.

Also, comparative evidence is lacking when looking at direct head-to-head comparisons against all other specific brands of artificial tear products. The follow-up durations were limited, often ranging from 4 to 8 weeks in duration, meaning limited information for long-term outcomes is available.

Key Studies & References

1. Efficacy of Carbomer-based Gel Eye Drops for the Treatment of Dry Eye Disease: A Systematic Review and Meta-Analysis (NCBI/PMC)
2. Vidisic 0.2% w/w Eye Gel - Product Information Leaflet (Health Products Regulatory Authority, Ireland)

Common questions about Vidisic Gel (FAQ)

Q: How does Vidisic Gel compare to ordinary eye drops?

Official product information describes Vidisic Gel as a substitute for natural tears that has a high viscosity. This gel consistency is designed to create a sustained physical layer on the eye's surface, which leads to a prolonged contact time compared to less viscous conventional eye drop formulations.

Q: Can Vidisic Gel be used for general eye irritation not related to dry eyes?

Regulatory documents state that the medicine is indicated for the symptomatic relief of dry eyes caused by insufficient natural tear production (sicca syndrome). Its use is not officially listed for general irritation. Furthermore, the product is contraindicated for patients with undiagnosed conjunctivitis (an eye infection).

Q: Are there any common side effects I should be aware of when using Vidisic Gel?

The most frequently reported experience related to the use of the gel is the potential for transient blurring of vision immediately after administration. According to official documents, other localized reactions in the eye, such as burning, stinging, or redness, are formally categorized as Rare undesirable effects.

Q: Can Vidisic Gel cause an allergic reaction?

The official product information states that Vidisic Gel is contraindicated (prohibited) for use if a patient has a known hypersensitivity to any component of the formulation. Swelling, redness, and inflammation of the eye are listed as Rare adverse reactions, which can be signs of an intolerance or allergic response.

Q: Does Vidisic Gel contain preservatives?

The standard formulation of Vidisic Gel contains the excipient cetrimide, which acts as a preservative.

Q: Is there a preservative-free version of Vidisic Gel available?

While the standard gel contains a preservative, official documents note that preservative-free medicinal products should be preferred for the long-term management of chronic dry eye conditions. This guidance reinforces the importance of preservative-free alternatives for chronic conditions.

Q: Is Vidisic Gel safe to use with glaucoma eye drops?

Official regulatory documents do not list glaucoma drops as a formal contraindication for use with Vidisic Gel. Regulatory documents describe a physical interference rule: the gel is required to be the last topical medication applied to the eye, and a 15-minute interval is observed after using any other eye drops.

Q: How long does the effect of Vidisic Gel usually last?

Studies and official product information indicate the Carbomer formulation is designed for a prolonged contact time on the eye's surface. The standard administration frequency, typically 3 to 5 times per day, including a scheduled application before sleep, supports the expectation that the product provides a sustained lubricating effect over several hours.

Q: Is Vidisic Gel intended for long-term use?

Regulatory guidance advises that preservative-free medicinal products should be preferred for the long-term treatment of chronic dry eye. This is due to the potential risk of ocular irritation from the preservative cetrimide when the preserved formulation is used frequently or for extended periods.

Q: Are there any special considerations for using Vidisic Gel in older adults?

Official regulatory documents state that use in adults and the elderly is established and generally accepted. No special or modified dosing regimen or precautions specifically targeted at older adults are mentioned in the official guidance.

Q: Why do some people report that Vidisic Gel feels sticky?

The feeling is related to the gel's designed physical properties: its high viscosity and its ability to adhere to the eye's surface, known as mucoadhesion. These characteristics help the product stay in place longer than liquid drops, forming a protective, stable film for lubrication.

Q: What are the ingredients besides the active substance in Vidisic Gel?

The official product documents list the excipients (non-active substances) as cetrimide (the preservative), sorbitol, sodium hydroxide, and water for injections.

Q: Does Vidisic Gel have an effect on natural tear production?

Vidisic Gel is officially classified as a substitute for lacrimal fluid. Its mechanism of action is physical, working to form a lubricating film on the eye's surface, and it is not documented in official documents as stimulating or otherwise altering the body’s natural tear production.

Q: What should I do if my eye redness seems to get worse after using the gel?

Official safety guidance requires that if a user experiences new or troubling eye symptoms, such as worsening redness, they discontinue use and consult a healthcare professional (doctor or pharmacist).

Q: Can men and women use Vidisic Gel the same way?

Official regulatory documents define usage based on age, and conditionally for pregnancy and lactation. They do not specify any differences in administration instructions, expected outcomes, or restrictions based on sex or gender.

Q: Does Vidisic Gel require a prescription from a doctor?

In many regulatory jurisdictions, Vidisic Gel is classified as a Pharmacy Only (P) medicine. This means it is non-prescription but must be supplied through a registered pharmacist.

Q: What happens if I accidentally use Vidisic Gel too often?

Regulatory documents state that overdose is generally considered 'Not relevant' due to the negligible systemic absorption of the active ingredient. In the event a user experiences any troubling adverse reaction or is concerned about frequency of use, official guidance suggests they report the issue to their doctor or pharmacist.

Q: Is it acceptable to share a tube of Vidisic Gel with another person?

Official guidance requires users to keep the nozzle tip clean and to avoid touching the eye or any surface to maintain sterility. For this reason, sharing multi-dose ophthalmic products is generally avoided to prevent the risk of cross-contamination between users.

Storage Requirements

Vidisic Gel must be stored strictly at a temperature that does not exceed 30 C, as required by regulatory labeling. It is essential to keep the product out of the sight and reach of children.

Stability and Handling

To maintain sterility, the product is only guaranteed sterile until first opened. For product supplied in a tube, it must be thrown away 1 month after first opening; it should not be used past this date or the printed expiry date. The nozzle tip must be kept clean and must not touch the eye or any surface during handling.

Disposal Instructions

Unused or expired Vidisic Gel must not be disposed of via household waste or wastewater. These medicines must be discarded using proper environmental measures, typically by asking a pharmacist for instructions on safe disposal.